CohBar, Inc. (NASDAQ:CWBR – Get Free Report) shares rose 12.5% on Wednesday . The company traded as high as $0.90 and last traded at $0.90. Approximately 356 shares traded hands during mid-day trading, a decline of 89% from the average daily volume of 3,366 shares. The stock had previously closed at $0.80.
CohBar Price Performance
The business’s 50 day moving average is $0.82 and its two-hundred day moving average is $1.08. The firm has a market capitalization of $2.62 million, a PE ratio of -0.21 and a beta of 1.54.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in the business. RVW Wealth LLC bought a new position in shares of CohBar in the fourth quarter worth approximately $4,029,000. Millennium Management LLC grew its holdings in shares of CohBar by 241.1% in the second quarter. Millennium Management LLC now owns 208,603 shares of the company’s stock worth $40,000 after purchasing an additional 147,442 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of CohBar by 88.5% in the third quarter. Vanguard Group Inc. now owns 33,293 shares of the company’s stock worth $103,000 after purchasing an additional 15,628 shares during the last quarter. 2.47% of the stock is owned by hedge funds and other institutional investors.
CohBar Company Profile
CohBar, Inc, a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.
Featured Stories
- Five stocks we like better than CohBar
- How to Read Stock Charts for Beginners
- United Airlines Soars on Earnings Beat
- About the Markup Calculator
- J.B. Hunt Hits the Skids: Lower Prices to Come
- How to Use the MarketBeat Excel Dividend Calculator
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for CohBar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CohBar and related companies with MarketBeat.com's FREE daily email newsletter.